Submitted by Anonymous (not verified) on 25 June 2025 - 10:35
Opinion/decision on a Paediatric investigation plan (PIP): Recarbrio, imipenem monohydrate,cilastatin sodium,relebactam (MK-7655A), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0190/2024
Source: